Apimostinel (NRX-1074; AGN-241660) is an orally active NMDA receptor partial agonist.
性状
Solid
体外研究(In Vitro)
Apimostinel (NRX-1074) modulates the NMDA receptor in a similar fashion to GLYX-13, but has a synthetic modification to one of the amino acids, conferring increased potency and oral bioavailability. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
In preclinical models the two compounds both appear to be highly efficacious across a number of CNS disorders. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
4°C, stored under nitrogen In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
ClinicalTrial
参考文献
[1]. Naurexs First Orally Active Molecule, NRX-1074, Demonstrates Statistically Significant Improvement in Depression Scores within 24 Hours in Phase 2 Study for Major Depressive Disorder. January 28, 2015.
溶解度数据
In Vitro: DMSO : 155 mg/mL (307.79 mM; Need ultrasonic)H2O : ≥ 6.67 mg/mL (13.24 mM)